Leiomyosarcoma in Birt-Hogg-Dubé Syndrome
暂无分享,去创建一个
Birt-Hogg-Dubé syndrome (BHDS) is an autosomal dominant genodermatosis characterized by benign cutaneous tumors (fibrofolliculomas, trichodiscomas, and acrochordons), basal lung cysts, pneumothoraces, and a 20% to 30% lifetime risk for renal cancer. There are isolated cases of other cancers in BHDS reported in the literature, including oncocytoma, rhabdomyoma, melanoma, thyroid cancer, meningioma, colon cancer, and breast cancer, but only the increased renal cancer risk has been substantiated. This is the case of a 9-year-old girl who presented with a leiomyosarcoma whose tumor genetic analysis showed FLCN c.365_372del, p.Arg122Leufs*8. She was diagnosed with BHDS when the same mutation was confirmed in her germline lymphocytes. This is the second known reported case of leiomyosarcoma in BHDS.
[1] W. Linehan,et al. FLCN: The causative gene for Birt-Hogg-Dubé syndrome. , 2018, Gene.
[2] A. Lencastre,et al. Birt-Hogg-Dubé syndrome* , 2013, Anais brasileiros de dermatologia.
[3] S. Steinberg,et al. BHD mutations, clinical and molecular genetic investigations of Birt–Hogg–Dubé syndrome: a new series of 50 families and a review of published reports , 2008, Journal of Medical Genetics.
[4] P. Postmus,et al. Birt-Hogg-Dubé syndrome: clinical and genetic studies of 20 families. , 2008, The Journal of investigative dermatology.